Apollo Hospitals (Large Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
Apollo Hospitals Enterprise Limited |
|||
Price: ₹6,919.15 (+2.04%) | |||
52 Week Low: ₹5,693.20 52 Week High: ₹7,545.35 |
|||
Market Capital: 96,938.4 Crore (Largecap) | |||
Healthcare -> Medical Care Facilities |
Show Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Apollo Hospitals Share Price Target For 2025
- 1.1.1: Apollo Hospitals Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Apollo Hospitals Share Price Target For 2026
- 1.2.1: Apollo Hospitals Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Apollo Hospitals Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Apollo Hospitals Brief Company Overview
- 4: Apollo Hospitals Financial Performance
- 4.0.1: Is Apollo Hospitals A Good Buy For Long Term?
Apollo Hospitals, a Large Cap company in the Medical Care Facilities Industry has delivered 322.7% returns in 5-year showing 15.3% quarterly revenue growth with 5.8% profit margin, making it a potential Multibagger.
To predict the Apollo Hospitals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Apollo Hospitals Share Price Target For 2025
The line chart displays the monthly closing prices of Apollo Hospitals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Apollo Hospitals shares in 2025, see the table below.
Apollo Hospitals Share Price Target Table For 2025
Level | Value | Analysis |
---|---|---|
2025 Target 3 | 7358.32 (+6.34%) | Fibonacci Extension Level 23.60% |
2025 Target 2 | 7277.35 (+5.17%) | Price Action: 13 Dec 2024 High |
2025 Target 1 | 7200.0 (+4.05%) | Price Action: 24 Sep 2024 High |
Current Price | 6919.15 | Apollo Hospitals's share price as of 21 Jan 2025 |
Stop Loss 1 | 6790.05 (-1.87%) | Price Action: Sep 2024 Low |
Stop Loss 2 | 6714.8 (-2.96%) | Price Action: 16 Aug 2024 High |
Stop Loss 3 | 6644.23 (-3.98%) | Price Action: 16 Feb 2024 High |
Short-Term Technical Outlook
Current Technical Position: Apollo Hospitals is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹7102.18 serves as the nearest technical reference point.
Historical Returns: 3-month: -1.47% | 6-month: +4.75% | 1-year: +9.18%
Apollo Hospitals Share Price Target For 2026
The line chart displays the monthly closing prices of Apollo Hospitals with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Apollo Hospitals shares in 2026, see the table below.
Apollo Hospitals Share Price Target Table For 2026
Level | Value | Analysis |
---|---|---|
2026 Target 3 | 9422.39 (+36.17%) | Price Action: Chart |
2026 Target 2 | 9246.7 (+33.63%) | Fibonacci Extension Level 150.00% |
2026 Target 1 | 9127.5 (+31.91%) | Fibonacci Extension Level 64.90% |
Current Price | 6919.15 | Apollo Hospitals's share price as of 21 Jan 2025 |
Stop Loss 1 | 6413.05 (-7.32%) | Price Action: Jan 2024 High |
Stop Loss 2 | 6347.71 (-8.26%) | Price Action: 08 Feb 2024 High |
Stop Loss 3 | 6283.14 (-9.19%) | Price Action: 08 Jul 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Apollo Hospitals is currently trading at 66.2% of its 52-week range (₹5693.2 - ₹7545.35).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +9.18% | 3-year: +56.82% | 5-year: +322.74%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Apollo Hospitals Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
Year | Target 1 | Target 1 YoY Chg % | Target 2 |
---|---|---|---|
Current Price | ₹6,919.15 | ||
2025 | ₹10,276.42 | +48.52% | ₹10,430.57 |
2026 | ₹11,974.98 | +16.52% | ₹12,154.60 |
2027 | ₹14,242.45 | +18.93% | ₹14,456.09 |
2028 | ₹18,607.46 | +30.64% | ₹18,886.57 |
2029 | ₹25,277.34 | +35.84% | ₹25,656.50 |
2030 | ₹32,764.07 | +29.61% | ₹33,255.53 |
2031 | ₹39,024.41 | +19.1% | ₹39,609.78 |
2032 | ₹48,019.46 | +23.04% | ₹48,739.75 |
2033 | ₹56,536.87 | +17.73% | ₹57,384.92 |
2034 | ₹70,693.76 | +25.04% | ₹71,754.17 |
2035 | ₹80,140.43 | +13.36% | ₹81,342.54 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Apollo Hospitals Brief Company Overview
Company Overview: Apollo Hospitals Enterprise Limited Apollo Hospitals Enterprise Limited is a leading healthcare provider in India, with a presence in over 100 countries. The company offers a wide range of healthcare services, including primary, secondary, and tertiary...
care facilities, as well as specialized services in cardiac sciences, orthopedics, oncology, and neurosciences. Apollo Hospitals also operates pharmacies, primary care clinics, and diagnostic centers, and provides other services such as project consultancy, health insurance, and medical colleges. Apollo Hospitals was founded in 1979 and has since grown to become one of the most respected healthcare providers in India. The company is committed to providing high-quality healthcare services at an affordable cost, and has a strong focus on research and innovation. Apollo Hospitals has a diverse product range that caters to the needs of patients of all ages and backgrounds. The company's services are available through a network of over 1,000 hospitals and clinics, and are also available online through Apollo 24/7, the company's digital health platform. Apollo Hospitals is a trusted name in the healthcare industry, and is known for its high-quality services and its commitment to patient care.Apollo Hospitals Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 96,938.4 Crore | Market valuation of Apollo Hospitals's shares. |
Revenue (TTM) | 20,469.39 Crore | Total revenue generated by Apollo Hospitals over the past twelve months. |
Net Income (TTM) | +1,187.59 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | +11.28% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | +5.8% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) |
+15.3% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) |
+69.89% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio |
93.13 | Company's total debt divided by total shareholder equity. |
Total Debt | 7,371 Crore | Sum of Apollo Hospitals's current & long-term financial obligations. |
Total Cash | 2,908.3 Crore | Total amount of liquid funds available to Apollo Hospitals. |
Beta | 0.59 | Beta is less than 1 indicating that the Apollo Hospitals's price is less volatile than the market. |
Is Apollo Hospitals A Good Buy For Long Term?
Apollo Hospitals, a large-cap stock with a market capitalization of ₹96,938.4 crore, shows strong growth potential. While its Q2 2024-25 debt (₹7,371 crore) is notable, a healthy cash balance of ₹2,908.3 crore mitigates some risk. Impressive past performance (450.97% return over 5 years) and a positive YTD return of 21.58% are encouraging. However, a 5.8% profit margin suggests room for improvement. Considering its growth trajectory and substantial returns, Apollo Hospitals is a good buy for the long term, but investors should monitor its debt levels.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.